Eliminating transseptal sheath exchange for pulsed field ablation procedures using a direct over-the-needle transseptal access with the Faradrive sheath. Issue 4 (9th March 2023)

• Record Type: Journal Article
• Authors: Kueffer, Thomas; Madaffari, Antonio; Thalmann, Gregor; Mühl, Aline; Galuszka, Oskar; Baldinger, Samuel; Seiler, Jens; Tanner, Hildegard; Kobza, Richard; Roten, Laurent; Berte, Benjamin; Reichlin, Tobias
• Is Part Of: Europace. Volume 25:Issue 4(2023)
• Page Start: 1500
• Page End: 1502
• Publication Date: 2023-03-09
• Subjects: Pulsed field ablation -- Transseptal puncture -- Air embolism; Arrhythmia -- Treatment -- Periodicals; Cardiac pacing -- Periodicals; Catheter ablation -- Periodicals; Heart -- Physiology -- Periodicals; Electrophysiology -- Periodicals; 617.4120645
• DOI: 10.1093/europace/euad060
• Languages: English
• ISSNs: 1099-5129

Abstract

Abstract: Aims: Pulsed field ablation (PFA) for pulmonary vein isolation (PVI) combines the benefits of high procedural efficacy and safety. Transseptal puncture (TSP) to obtain left atrial (LA) access during PVI remains an important source of complications during LA procedures. For PFA procedures, TSP is generally performed using a standard transseptal sheath that is then exchanged over the wire for a dedicated PFA sheath, which might be a potential source for air embolism. We aimed to prospectively evaluate the feasibility and safety of a simplified workflow using the PFA sheath (Faradrive, Boston Scientific) directly for TSP. Methods and Results: We prospectively enrolled 100 patients undergoing PVI using PFA at two centres. TSP was performed using the PFA sheath and a standard 98 cm transseptal needle under fluoroscopic guidance. TSP via the PFA sheath was successfully performed in all patients and no complications occurred. The median time from the first groin puncture to the completed LA access was 12 min (IQR 8–16 min). Conclusion: An over-the-needle TSP directly with the PFA sheath proved feasible and safe in our study. This simplified workflow has the potential to reduce the risk of air embolism, to shorten procedure time, and to reduce cost.